WHO: Covid-19 antiviral drug molnupiravir recommendation
WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission: The antiviral drug molnupiravir is…
WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission: The antiviral drug molnupiravir is…
Dangerously low medical oxygen supplies in Ukraine due to crisis, warn WHO Director-General and WHO Regional Director for Europe: Dr…
Health experts fear impact of deteriorating hostile environment: Patient rights must be protected as UK policies and government rhetoric indicate a…
Skiing Peaks: analysis of alpine pollution: Data scientists at cleantech Airly have crunched the numbers on air pollution levels at…
Diet, malaria and substance use linked to Pacific preterm births. A new Curtin University study has found diet, malaria, substance…
Covid prevention campaign launched for vulnerable communities in Zimbabwe: A public health expert at the University of Wolverhampton is working…
WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners: At the European…
Coronavirus booster vaccination also protects cancer patients: People with cancer are often given immunosuppressive treatments that weaken their innate immune…
Two years into the pandemic, health systems are still facing significant challenges in providing essential health services. Ongoing disruptions have…
A new FMG course to help health and social care workers understand the many impacts of female genital mutilation (FGM)…
This website uses cookies.